ZA200308465B - An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases. - Google Patents

An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.

Info

Publication number
ZA200308465B
ZA200308465B ZA200308465A ZA200308465A ZA200308465B ZA 200308465 B ZA200308465 B ZA 200308465B ZA 200308465 A ZA200308465 A ZA 200308465A ZA 200308465 A ZA200308465 A ZA 200308465A ZA 200308465 B ZA200308465 B ZA 200308465B
Authority
ZA
South Africa
Prior art keywords
adenosine
combination
receptor agonist
anticholinergic agent
obstructive airways
Prior art date
Application number
ZA200308465A
Inventor
Michael Yeadon
Roisin A Armstrong
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA200308465B publication Critical patent/ZA200308465B/en

Links

ZA200308465A 2001-05-25 2003-10-30 An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases. ZA200308465B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29384201P 2001-05-25 2001-05-25

Publications (1)

Publication Number Publication Date
ZA200308465B true ZA200308465B (en) 2004-11-01

Family

ID=34572599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200308465A ZA200308465B (en) 2001-05-25 2003-10-30 An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.

Country Status (3)

Country Link
CR (1) CR7162A (en)
EC (1) ECSP034863A (en)
ZA (1) ZA200308465B (en)

Also Published As

Publication number Publication date
ECSP034863A (en) 2004-01-28
CR7162A (en) 2004-02-23

Similar Documents

Publication Publication Date Title
IL158774A0 (en) An adenosine a2a receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases
HK1049007B (en) Adenosine a2a receptor antagonists
IL130424A (en) Compositions comprising ziprasidone or its hydrochloride monohydrate, their preparation and use thereof in the preparation of medicaments for treating psychosis
PT2942082T (en) A2a receptor antogonists for use in the treatment of movement disorders
PL377791A1 (en) 3-amino-piperidine derivatives and processes for their preparation
HK1042236A1 (en) Nociceptin receptor orl-1 agonists for use in treating cough
AU2003273300A8 (en) Modified glp-1 receptor agonists and their pharmacological methods of use
IL136461A0 (en) Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
EP1368053A4 (en) Compositions and methods for treating gonadotrophin related illnesses
HK1063780A1 (en) Adenosine a2a receptor antagonists
IL161572A0 (en) Adenosine a2a receptor antagonists
WO2000072799A3 (en) Method and compositions for treating the inflammatory response
IL196384A0 (en) Corticotropin releasing factor 2 receptor agonists
AU2001238665A1 (en) Method of identifying partial agonists of the a2a receptor
AU5977501A (en) Method for treating retinal degeneration with purinergic receptor agonists
AU2001259775A1 (en) Method for treating retinal degeneration with purinergic receptor agonists
GB2389201B (en) Methods and system for using caches
PL367627A1 (en) 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
ZA200308465B (en) An adenosine A2A receptor agonist and an anticholinergic agent in combination for treating obstructive airways diseases.
MXPA03001609A (en) Chromenone derivatives and their use for treating diseases in conjunction with 5-hta1 receptors and/or dopamine d2 receptors.
EP1427429A4 (en) Compositions and methods for treating subjects with hyperglycemia
HUP0700046A2 (en) Crytalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist, manufacture use thereof and pharmaceutical composition containing thereof
AU5297299A (en) Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use
GB0201284D0 (en) Screening methods for contraceptive and fertility agents
GB2401042B (en) Antitussive agent and method for making the same